Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.66 USD | 0.00% | +3.79% | -25.68% |
Business Summary
Number of employees: 136
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 0 | nan % | 14 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 14 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Tucker
CEO | Chief Executive Officer | 61 | 01/17/01 |
Rachael Nokes
DFI | Director of Finance/CFO | 49 | 01/14/01 |
John Mohr
CTO | Chief Tech/Sci/R&D Officer | - | 01/17/01 |
Mike Hassman
CTO | Chief Tech/Sci/R&D Officer | - | 01/18/01 |
Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 01/14/01 | |
Klaus Veitinger
BRD | Director/Board Member | 62 | 21/17/21 |
John Tucker
CEO | Chief Executive Officer | 61 | 01/17/01 |
Frederick Hudson
BRD | Director/Board Member | 78 | 19/18/19 |
William Abraham
BRD | Director/Board Member | 64 | 16/21/16 |
Jack Khattar
CHM | Chairman | 62 | 12/16/12 |
Mette Agger
BRD | Director/Board Member | 59 | 01/14/01 |
Director/Board Member | 76 | 24/18/24 | |
Sara Bonstein
BRD | Director/Board Member | 43 | 08/20/08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,054,409 | 29,518,053 ( 81.87 %) | 0 | 81.87 % |
Company contact information
scPharmaceuticals, Inc.
25 Burlington Mall Road Suite 203
01830, Burlington
+617 517 0730
http://www.scpharmaceuticals.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.68% | 168M | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B |
- Stock Market
- Equities
- SCPH Stock
- Company scPharmaceuticals Inc.